Terminal deoxynucleotidyl transferase activity in malignant lymphomas

Area of Science:

• Biochemistry
• Oncology
• Immunology

Background:

• Lymphoma diagnosis and classification rely on various markers.
• Identifying specific lymphoma subtypes can be challenging.
• Terminal deoxynucleotidyl transferase (TdT) is an enzyme with potential diagnostic utility.

Purpose of the Study:

• To evaluate the usefulness of terminal deoxynucleotidyl transferase (TdT) enzyme activity as a biochemical marker in lymphoma.
• To determine if TdT activity can differentiate between lymphoma subtypes.

Main Methods:

• Assayed TdT enzyme activity in 50 malignant lymphoma samples and normal lymphoid tissue.
• Analyzed TdT activity in various lymphoma types, including Hodgkin's disease, Burkitt's tumor, and different lymphocytic lymphomas.
• Correlated TdT activity with cell surface immunomarkers.

Main Results:

• TdT activity was notably absent in Hodgkin's disease, Burkitt's tumor, Sézary's syndrome, chronic lymphocytic leukemia, leukemic reticuloendotheliosis, and poorly differentiated/intermediate lymphocytic lymphomas.
• Large-cell B-cell tumors were negative for TdT activity.
• One large-cell tumor lacking B-cell or T-cell specificity showed low TdT activity (1.40 nmol/hr/mg DNA).
• TdT activity was consistently present in all six lymphoblastic lymphoma cases studied, with a mean activity of 7.80 nmol/hr/mg DNA.
• The lymphoblastic lymphomas with TdT activity exhibited heterogeneous surface immunomarkers.

Conclusions:

• Terminal deoxynucleotidyl transferase (TdT) enzyme activity serves as a valuable biochemical marker in lymphoma research.
• TdT activity is a key indicator for identifying lymphoblastic lymphomas.
• The presence of TdT activity aids in the specific study and potential diagnosis of certain lymphoma subtypes.